For Vax Providers, Flu Season Off to a Running Start

It’s flu season again, and more than 690,000 people in the U.S. have already been vaccinated, reports healthcare analytics service SDI.

Read more »

As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181

DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.

Read more »

Bioguard Wound Dressings Beat Swine Flu In Independent Study

Derma Sciences, a developer of wound care products, announced that its Bioguard Barrier Dressings effectively safeguarded against the H1N1 “swine flu” virus in an independent laboratory study.

Read more »

Biotech News Out of Quebec

Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.

Read more »

First Swine Flu Vaccines Approved

The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.

Read more »

BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows

BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test.

Read more »

Independent Study Validates BioNeutral’s Ygiene

In an independent study, BioNeutral’s Ygiene antimicrobial formulation eliminated a particularly dangerous type of mold in record time.

Read more »

Frontrunners Emerge In Swine Flu Vaccine Race

Just days after the World Health Organization declared a swine flu pandemic, Fierce Biotech reports that two pharmaceutical companies are already racing to complete clinical trials of their H1N1 vaccines.

Read more »

Companies Rush to Create Swine Flu Vaccines

With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.

Read more »